Venous Thromboembolism Trials in colombes, france
Conditions / Venous Thromboembolism / colombes, france
18 total trials for this combination
Showing top 10 of 18 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT01362933 | National Evaluation of the Adherence to Recommendations of Venous Thrombo Embolism Treatment in Cancer Patients | COMPLETED | — |
| NCT00986154 | Comparative Investigation of Low Molecular Weight (LMW) Heparin/Edoxaban Tosylate (DU176b) Versus (LMW) Heparin/Warfarin in the Treatment of Symptomatic Deep-Vein Blood Clots and/or Lung Blood Clots. (The Edoxaban Hokusai-VTE Study). | COMPLETED | PHASE3 |
| NCT03045406 | Apixaban for the Treatment of Venous Thromboembolism in Patients With Cancer | COMPLETED | PHASE3 |
| NCT02832245 | Computerized Registry of Patients With Venous Thromboembolism (RIETE) | RECRUITING | — |
| NCT05171075 | A Study Comparing Abelacimab to Dalteparin in the Treatment of Gastrointestinal/Genitourinary Cancer and Associated VTE | ACTIVE_NOT_RECRUITING | PHASE3 |
| NCT00571649 | Venous Thromboembolic Event (VTE) Prophylaxis in Medically Ill Patients | COMPLETED | PHASE3 |
| NCT00439725 | Once - Daily Oral Direct Factor Xa Inhibitor Rivaroxaban In The Long-Term Prevention Of Recurrent Symptomatic Venous Thromboembolism In Patients With Symptomatic Deep-Vein Thrombosis Or Pulmonary Embolism. The Einstein-Extension Study | COMPLETED | PHASE3 |
| NCT05171049 | A Study Comparing Abelacimab to Apixaban in the Treatment of Cancer-associated VTE | TERMINATED | PHASE3 |
| NCT02064439 | Reduced-dosed Rivaroxaban in the Long-term Prevention of Recurrent Symptomatic VTE(Venous Thromboembolism) | COMPLETED | PHASE3 |
| NCT02379806 | The SYMPTOMS - SYstematic Elderly Medical Patients Thromboprophylaxis: Efficacy on Symptomatic OutcoMeS - Study | COMPLETED | PHASE3 |